Alexandria, VA -- The new FDA Commissioner, Dr. Jane Henney, will arrive at FDA in time to participate in the 1998 FDA Science Forum, co-sponsored by the American Association of Pharmaceutical Scientists (AAPS). Dr. Henney will discuss the importance of science in biotechnology regulation with FDA scientists and the external scientific community.
AAPS is co-sponsoring the 1998 FDA Science Forum, titled "Biotechnology: Advances, Applications, and Regulatory Challenges," with FDA and the FDA Chapter of Sigma Xi at the Washington Convention Center in Washington, D.C., Dec. 8-9, 1998.
The FDA Science Forum is open to the public and will bring FDA research and review scientists together with representatives of industry, academia, government agencies, consumer groups, and the public to discuss the impact of the enormous advances in biotechnology on product development and regulation. The program will encompass bioengineered products, novel therapeutic and preventive approaches, diagnostics and detection methodologies, and safety and efficacy assessment. Regulatory issues related to standards, product quality and the impact of the Food and Drug Administration Modernization Act (FDAMA) will also be addressed. For more information, contact: AAPS, 703-548-3000, email: meetings@aaps.org, www.aaps.org/edumeet.html (registration materials available online).
The American Association of Pharmaceutical Scientists is a professional, scientific society of more than 9,300 members employed in academia, industry, government, and other research institutions worldwide. Founded in 1986, the goal of AAPS is to improve human health through the development of better pharmaceuticals.